Earnings calls / TATAELXSI · July 14, 2026

Tata Elxsi Limited Q1 FY27 Earnings Call Summary

Tata Elxsi reported Q1 FY27 revenue of ₹1,021.1 crore, up 6.5% YoY in constant currency, with media & communication growing 11.5% YoY CC and transportation 6.7% YoY CC while healthcare slipped 0.3% QoQ CC. EBIT margin fell 330 bps QoQ because of ~150 bps one-offs, including a customer Chapter 11 provision, and ~220 bps US transition, subcontractor and AI investments. Management kept its high-single-digit FY27 CC growth aspiration, expects healthcare to return to growth during the year, and sees margins recovering sequentially from Q2 as one-offs fade. Main risks are slower German OEM ramp-ups, visa-driven onsite cost stickiness, and delayed healthcare deal awards.

Revenue
Margin
Demand
Guidance
Tone

Event Participants

Executives (4)

Manoj Raghavan, Nalin Rana, Nitin Pai, Sneha V

Analysts (11)

Abhishek Shindadkar, Amit Chandra, Bhavik Mehta, Karan Uppal, Karthik, Moez Chandani, Randhir Singh, Ravi Menon, Rishi Mody, Sulabh Govila, Vimal Jamnadas Gohil

Financials & KPIs

Metric Reported Commentary
Operating Revenue ₹1,021.1 crores First quarter above ₹1,000 crores milestone; constant currency growth of 6.5% YoY and 1.3% QoQ
Revenue Growth (CC) +6.5% YoY / +1.3% QoQ Led by transportation (+6.7% YoY CC) and media & communication (+11.5% YoY CC); healthcare near flat
Transportation Vertical +6.7% YoY CC / +13.3% YoY NC Over 55% of SDS segment revenue; driven by large automotive OEM engagements plus strategic off-road and aerospace deal wins
Media & Communication +11.5% YoY CC / +22.2% YoY NC / +4.7% QoQ NC Full ramp-up of engagements announced in prior quarters; large programs with global operators and broadcasters
Healthcare & Life Sciences -0.3% QoQ CC Near flat; delayed deal awards from key customers; less than 10% of revenue
EBITDA ₹216 crores Grew 15.7% YoY; EBITDA margin of 21.2%
EBIT Margin Change -330 bps QoQ / +80 bps YoY ~150 bps one-off costs (transition, retention, customer Chapter 11 provision, upfronted annual costs) and ~220 bps investments (onsite ramp-up, subcontractors, AI tools) partially offset by 40-50 bps cross-currency gains
Onsite-Offshore Mix 74% offshore / 26% onsite ~90 bps shift toward onsite in one quarter due to US deal transition requirements and visa delays
Utilization 74.7% Just above 75%; supports moderated fresher hiring approach
Attrition ~16% Retention actions taken for critical niche talent amid GCC competition

Geographic & Segment Commentary

  • Transportation: Grew 6.7% YoY CC (13.3% YoY natural) despite a challenged European macro environment, with >55% of SDS segment revenue. Growth was led by large automotive OEM engagements and off-road/farm equipment plus aerospace & defense adjacencies; OEM customers now contribute 78% of automotive revenue. Germany remains soft with slower-than-expected ramp-ups, offset by US and APAC recovery; Europe still accounts for slightly over 40% of automotive revenue, US ~25-30%, remainder APAC.

  • Media & Communication: Delivered robust growth of 11.5% YoY CC (22.2% YoY natural) and 4.7% QoQ in natural currency, driven by ramp-up of deals announced in earlier quarters and large consolidation programs with global operators and broadcasters. The vertical benefited from media/telecom M&A activity where Tata Elxsi was the incumbent or prime vendor, enabling market share gains through an offshore-centric value proposition.

  • Healthcare & Life Sciences: Exited near flat at -0.3% QoQ CC due to delayed deal awards from key customers despite building AI/GenAI capabilities. The vertical is less than 10% of revenue; management expects growth within FY27 and continues investing in platforms like ViTel and AnaTel and medtech event presence.

  • US Region: Performed well across verticals led by new deal wins and ramp-ups, but strategic programs required rapid onshore ramp-up for transition support and stabilization. Additional costs were incurred for forward teams and specialist third-party contractors to mitigate visa delays; this is partly reflected in the onsite-offshore ratio and is expected to ease over the next two to three quarters.

Company-Specific & Strategic Commentary

  • Platform-led offerings: Neuron platform portfolio enabled Sky in Europe to transition toward zero-touch network operations with enhanced cybersecurity, delivering 30-70% efficiencies across various parameters. AI-led material intelligence platform ViTel signed a strategic deal with a global medtech company.

  • AI and capability investments: Company is intensifying investments in specialized talent, rigorous upskilling, AI-powered platforms, tools and cloud infrastructure to strengthen its "human + AI + domain" proposition. Sales headcount added in both US and Europe, advisors brought in for large deal pursuits, and spend directed at specialized industry events rather than large generic ones.

  • Business model discipline: Offshore-centric delivery model remains unchanged at target ~75/25 offshore/onsite (currently 74/26). Subcontractor usage is a short-term bridge driven by visa constraints and transition timelines, with own employees replacing contractors as visas are approved over the next few quarters.

  • M&A consolidation opportunity: Media/telecom industry consolidation expanded Tata Elxsi's addressable project pool — as incumbent or prime vendor in M&A situations, the company won business from competitors by demonstrating superior execution and offshoring capability. In cases where acquired customers had no India footprint, the acquirer engaged Tata Elxsi after evaluating its operations.

Guidance & Outlook

Metric Guidance / Outlook Commentary
CC Revenue Growth (FY27) High-single-digit aspiration maintained Management reaffirmed despite healthcare softness and German market challenges; healthcare must return to growth for achievement
EBIT Margins (Q2-Q4 FY27) ~150 bps one-offs to reverse in Q2; sequential recovery toward Q4 Q2 will balance company-wide wage hike impact against removal of one-off costs; ~220 bps investment costs to ease as subcontractors are replaced and work moves offshore
Healthcare (FY27) Return to growth during FY27 Deal awards delayed but pipeline strong; management continues investing in capabilities
Onsite-Offshore Mix Normalize to ~75/25 over next 2-3 quarters US transition costs to ease as own employees replace third-party contractors
Adjacency Revenue Disclosure By end of FY27 Management expects to quantify off-road, farm equipment and aerospace revenues

Risks & Constraints

Risk Context
Customer Chapter 11 A customer filed for Chapter 11, forcing conservative provisioning on receivables in Q1; a key driver of the other expenses increase and not expected to recur
Visa & immigration constraints H-1B and other visa delays/restrictions increase reliance on expensive subcontractors and pressure margins; large fee increases (~US$100,000 for H-1B) cannot be passed through to customers and must be absorbed in rates
European automotive weakness German OEM market challenges are causing slower ramp-ups and delayed deal decisions; Continental Europe is wait-and-watch, though US and APAC are offsetting
Healthcare deal slippage Delayed deal awards from key customers pushed healthcare to near-flat QoQ; management calls it a "moving target" but expects FY27 growth
AI-driven budget reallocation Clients prioritizing AI spend is curtailing some R&D budgets — a right-shifting rather than permanent deferment; management sees platform-led offerings offsetting any deflation risk
Talent competition from GCCs Attrition at ~16%; global capability centers competing aggressively for niche AI-ready domain talent, driving retention costs and a Q2 company-wide wage hike

Q&A Highlights

Vertical Outlook and FY27 Growth Aspiration

  • Question: What is the outlook across the three verticals given the Middle East conflict, and how should margins trend? (Bhavik Mehta, JP Morgan)
  • Answer: Media & communication should continue growing over the next 2-3 quarters given large consolidation deals in the pipeline; transportation is resilient with US and APAC offsetting German softness; healthcare is a "moving target" but expected to grow within FY27 (Manoj Raghavan). Margins: ~150 bps of one-off costs should go away in the next quarter; ~220 bps of investment costs are stickier but should normalize over time (Nalin Rana).
  • Question: Is the high-single-digit FY27 growth aspiration still valid? (Moez Chandani, Ambit Capital)
  • Answer: The aspiration is unchanged; it requires the healthcare business to "fire up" (Manoj Raghavan).

Margin Bridge and Q2 Trajectory

  • Question: Does the ₹135 crore other expenses line include forex losses? (Vimal Jamnadas Gohil, Alchemy Capital)
  • Answer: No significant forex item; the increase is driven by a Chapter 11 customer provision on a conservative basis and upfronting of certain annual costs (Nalin Rana).
  • Question: Is ~19% EBIT margin the floor with improvement ahead? (Karan Uppal, PhillipCapital)
  • Answer: Q2 will see a balance between the company-wide wage hike impact and removal of one-off costs; margins should ramp up sequentially through the year toward Q4 as revenues pick up (Nalin Rana).

US Onsite Investments — Structural or Tactical

  • Question: Does the onsite delivery investment represent a structural change from the offshore-centric model? (Sulabh Govila, Morgan Stanley)
  • Answer: Not structural — the long-term model remains ~75/25 offshore/onsite (currently 74/26); large US consolidation deals required temporary onsite presence and work will move back offshore over subsequent quarters (Manoj Raghavan).
  • Question: Are customers demanding subcontractor usage, and can wage hike quantum be shared? (Abhishek Shindadkar, InCred Capital)
  • Answer: Customers are not demanding contractors; visa constraints force subcontractor augmentation during transitions, managed through MOUs and partnerships (Manoj Raghavan). Wage hike details will be shared at end of Q2 (Manoj Raghavan). AI budgets are right-shifting R&D allocation rather than being permanently deferred (Nitin Pai).

Transportation and OEM Dynamics

  • Question: What is the transportation pipeline and role in hybrid platforms; what is the NBCU restructuring impact? (Ravi Menon, Axis Capital)
  • Answer: No clarity yet on NBCU impact but it could be positive since Tata Elxsi has not deeply penetrated that business; automotive traction is visible in US, APAC, Japan and India, while Continental Europe is wait-and-watch (Manoj Raghavan).
  • Question: How are top vs non-top OEM clients moving, and will transportation grow sustainably from Q2? (Amit Chandra, HDFC Securities; Karan Uppal, PhillipCapital)
  • Answer: The top customer is steady; German OEM ramp-ups are slower than expected, but US and APAC recovery contributed to growth; SDV-related pipeline continues and transportation should grow in subsequent quarters (Manoj Raghavan).

AI Impact and Platform Strategy

  • Question: Will AI autonomous tools hurt ER&D more than IT services, and how are proprietary platforms being deployed? (Karthik, RK Investments)
  • Answer: Mission-critical industries adopt AI carefully; coding is a small part of the lifecycle — architecture, requirements capture and regulatory alignment dominate, and customers rank quality, time, then cost, protecting pricing (Nitin Pai). Platform investments are two-pronged: customer-facing platforms (Neuron, TETHER) transform products, while efficiency platforms (ViTel, AnaTel, DevStudio) accelerate SDLC; traction is strong with calibrated adoption, and platforms are already improving win ratios (Nitin Pai).

Media & Communication Consolidation Wins

  • Question: Is M&C growth industry-led or outperformance, and what happens when customers get acquired? (Rishi Mody, Mody Advisory)
  • Answer: The industry remains turbulent, but Tata Elxsi won because it was the incumbent or prime vendor in M&A situations, gaining access to larger project pools; in cases where acquired customers had no India footprint, the acquirer engaged Tata Elxsi after evaluating its operations and offshoring capability (Manoj Raghavan).

Visa Costs and Contractual Protection

  • Question: Do contracts have provisions for immigration/visa fee changes? (Rishi Mody, Mody Advisory)
  • Answer: Standard visa fee increases are absorbed and bundled into hourly rates and annual COLA negotiations; large increases such as ~US$100,000 H-1B fees cannot be passed to customers, so third-party contractors are used short-term via MOUs and partnerships (Manoj Raghavan).

Talent, Hiring and Retention

  • Question: What is the fresher hiring plan versus last year? (Ravi Menon, Axis Capital)
  • Answer: Hiring is in wait-and-watch mode with utilization at ~75%; only ~100-150 freshers were added last quarter, and laterals are hired only for specific needs given AI/GenAI productivity gains (Manoj Raghavan).
  • Question: Why retention interventions when industry attrition is low? (Sulabh Govila, Morgan Stanley follow-up)
  • Answer: Attrition is ~16%, but GCCs are aggressively hiring niche AI-ready domain talent, so retaining critical talent is essential to service expected revenue growth without scrambling to hire later (Manoj Raghavan).

Key Takeaway

Tata Elxsi crossed ₹1,000 crores in quarterly revenue for the first time at ₹1,021.1 crores in Q1 FY27, with 6.5% YoY constant currency growth led by media & communication (+11.5% YoY CC) as prior deal wins ramped up, and transportation (+6.7% YoY CC) holding up despite German OEM weakness; healthcare was near flat at -0.3% QoQ. EBITDA grew 15.7% YoY to ₹216 crores (21.2% margin), but EBIT margin fell 330 bps QoQ on ~150 bps of one-offs, including a customer Chapter 11 provision, and ~220 bps of investments tied to US deal ramp-ups, subcontractor usage and AI capability building. Management reaffirmed its high-single-digit FY27 CC growth aspiration, expects healthcare to turn positive within the year, and guides margins to recover sequentially from Q2 as one-offs fade, partly offset by a company-wide wage hike. Watch points include European OEM decision pacing, visa-driven onsite cost stickiness, and healthcare deal closure timing.

What you get with InvestorStack

Institutional-grade research, built for individual investors.

  • Research Reports for 1,800+ companies
  • Detailed valuation models
  • Growth triggers, Risks, KPIs, Read between the lines
  • Scans, One pagers, Industry research reports
Try for free